| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2014 | EP2683370A1 Thiol-containing compounds for the removal of elements from tissues and formulations therefor |
| 01/15/2014 | EP2683369A1 Multiantivirus compound, composition and method for treatment of virus diseases |
| 01/15/2014 | EP2683368A1 Treatment of disorders with altered vascular barrier function |
| 01/15/2014 | EP2683366A1 Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor |
| 01/15/2014 | EP2683365A1 Pharmaceutical formulation for producing rapidly disintegrating tablets |
| 01/15/2014 | EP2683361A1 Method for the preparaton of a levothyroxine solution |
| 01/15/2014 | EP2683352A2 Small molecule modulators of the cold and menthol receptor trpm8 |
| 01/15/2014 | EP2683256A1 Nutraceutical composition for limiting the absorption of dietary lipids and for inducing weight loss, comprising, as active agent, at least one extract of carrot |
| 01/15/2014 | EP2683245A1 Methods and compositions for treating depression using cyclobenzaprine |
| 01/15/2014 | EP2683244A1 Heterocyclic modulators of lipid synthesis |
| 01/15/2014 | EP2683243A2 Pi3 kinase inhibitors and uses thereof |
| 01/15/2014 | EP2683242A1 Effective amounts of (3ar)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl phenylcarbamate and methods thereof |
| 01/15/2014 | EP2403477B1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof |
| 01/15/2014 | EP2309990B1 Drug loaded polymeric nanoparticles and methods of making and using same |
| 01/15/2014 | EP1037926B1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 01/15/2014 | CN103517910A Morpholine-spirocyclic piperidine amides as modulators of ion channels |
| 01/15/2014 | CN103517908A Sesterterpene compounds and use thereof |
| 01/15/2014 | CN103517905A New hexahydropyrroloimidazolone compounds |
| 01/15/2014 | CN103517904A Alpha helix mimetics and methods relating thereto |
| 01/15/2014 | CN103517903A Pyrrolopyridineamino derivatives as MPS1 inhibitors |
| 01/15/2014 | CN103517902A Methods and compositions for treating beta-thalassemia and sickle cell disease |
| 01/15/2014 | CN103517901A 1,4-oxazepines as bace1 and/or bace2 inhibitors |
| 01/15/2014 | CN103517898A Novel 3-hydroxyisothiazole 1-oxide derivative |
| 01/15/2014 | CN103517896A Quinolinone derivatives |
| 01/15/2014 | CN103517895A Metal-salen complex compound and production method for same |
| 01/15/2014 | CN103517716A Tolerogenic synthetic nanocarriers for inducing regulatory b cells |
| 01/15/2014 | CN103517712A Neuropeptide analogs, compositions, and methods for treating pain |
| 01/15/2014 | CN103517711A Composition useful for the treatment of lipid metabolism disorders |
| 01/15/2014 | CN103517710A Compounds and methods for kinase modulation, and indications therefor |
| 01/15/2014 | CN103517709A A composition for treating autoimmune disorders and methods thereof |
| 01/15/2014 | CN103517708A Pharmaceutical composition |
| 01/15/2014 | CN103517707A Controlled release of immunosuppressants from synthetic nanocarriers |
| 01/15/2014 | CN103513020A Application of taurine in preparing preparation for detecting or preventing myocardial ischemia injury |
| 01/15/2014 | CN103509868A Application of nucleotide sequence |
| 01/15/2014 | CN103509181A New ionizing radiation damage resistance function of polyethyleneimine compounds, and its application |
| 01/15/2014 | CN103509077A Triterpene saponin compound, its preparation method and applications |
| 01/15/2014 | CN103509073A Citicoline sodium compound |
| 01/15/2014 | CN103509071A Preparation and application of active ingredients of glossy privet fruit |
| 01/15/2014 | CN103509046A Bis(tri(2-methyl-2-phenyl propyl)tin) dicarboxylic ester and preparation method and application thereof |
| 01/15/2014 | CN103509033A Beta-artemether polymorphic substances and preparation methods thereof |
| 01/15/2014 | CN103509030A Camptothecin compounds, and preparation and applications thereof |
| 01/15/2014 | CN103509024A Pyrimidobenzoazepine compound and application thereof as anti-tumor medicine |
| 01/15/2014 | CN103509023A Xanthine derivative |
| 01/15/2014 | CN103509017A Substituted pyrazolo[1,5-a]pyrimidine compounds as TRK kinase inhibitors |
| 01/15/2014 | CN103509015A Salts of 14-hydroxyantofine derivative |
| 01/15/2014 | CN103509014A Salts of antofine derivatives |
| 01/15/2014 | CN103509013A Salts of delta 11,12-antofine derivatives |
| 01/15/2014 | CN103509009A 2-substituted-5-phenyl furan compound, and preparation method, pharmaceutical composition and application thereof |
| 01/15/2014 | CN103509008A Derivatives of pyrazole-substituted amino-heteroaryl compounds |
| 01/15/2014 | CN103509007A Flumatinib mesylate crystal form and preparation method and use thereof |
| 01/15/2014 | CN103509006A Flumatinib mesylate crystal form, and preparation method and use thereof |
| 01/15/2014 | CN103509005A Quinazoline compound as well as preparation method and application thereof |
| 01/15/2014 | CN103509004A Dabigatran caffeic acid salt as well as preparation method and application thereof |
| 01/15/2014 | CN103509001A Esomeprazole magnesium trihydrate and preparation method thereof |
| 01/15/2014 | CN103508993A Preparation method of benzopyran compound and application of protecting against pulmonary fibrosis |
| 01/15/2014 | CN103508992A Preparation method for novel isoflavone amide derivatives and research on antioxidant activity of derivatives |
| 01/15/2014 | CN103508981A New piperazine derivative and medical applications |
| 01/15/2014 | CN103508980A Benzothiazine-4-one derivative, and preparation method and applications thereof |
| 01/15/2014 | CN103508961A Antitumor drug |
| 01/15/2014 | CN103508960A Benzoheterocyclic derivatives |
| 01/15/2014 | CN103508957A Hydroxyethyl pyrazole compound or aminoethyl pyrazole compound, preparation method and use thereof |
| 01/15/2014 | CN103508953A Salts of nuciferine derivatives |
| 01/15/2014 | CN103508952A Salts of N-nornuciferine derivatives |
| 01/15/2014 | CN103508951A Salts of 2-hydroxy-1-methoxyaporphine derivative |
| 01/15/2014 | CN103508943A Compound taken as potassium channel regulator |
| 01/15/2014 | CN103508931A Hexahydropentaleno derivatives, preparation methods and applications in medicine thereof |
| 01/15/2014 | CN103508930A Bis(aminodithioformate)-1,3-propane diester compound, and synthesis method, pharmaceutical composition and use thereof |
| 01/15/2014 | CN103508922A Dipeptide compound and use of the same in preparation of anti-complement drugs |
| 01/15/2014 | CN103508920A Preparation method for optical isomers of phenylalaninol compound and application thereof |
| 01/15/2014 | CN103508919A Alkaloid compound and use of the same in preparation of anti-complement drugs |
| 01/15/2014 | CN103505802A Mifepristone shell-type vaginal ring preparation and application |
| 01/15/2014 | CN103505741A Tegafur-layered double-metal hydroxide nanometer hybrid modified with polyethylene glycol derivative on surface and preparation of nanometer hybrid |
| 01/15/2014 | CN103505740A Cyclodextrin mifepristone clathrate compound, preparation method thereof, and pharmaceutical composition containing clathrate compound |
| 01/15/2014 | CN103505737A Method for preparing docetaxel/beta-cyclodextrin clathrates |
| 01/15/2014 | CN103505735A Composition containing r-aminobutyric acid, taurine and antiepileptic drugs |
| 01/15/2014 | CN103505734A Composition containing r-aminobutyric acid and antiepileptic drugs |
| 01/15/2014 | CN103505733A Oral liquid preparation with macrolides medicine as active component |
| 01/15/2014 | CN103505732A Tumor treatment synergism combination drug |
| 01/15/2014 | CN103505731A Applications of 1 type cysteinyl leukotriene receptor antagonist on preparation of medicament for treating the Alzheimer disease |
| 01/15/2014 | CN103505730A Copper selenide/mesoporous silica core-shell nanoparticles and preparation method and application thereof |
| 01/15/2014 | CN103505717A Composition containing mushroom mycelium polysaccharides and applications thereof |
| 01/15/2014 | CN103505699A Traditional Chinese medicine preparation for treating nervous headache |
| 01/15/2014 | CN103505697A Medicine used for treating orthopaedic diseases, and preparation method thereof |
| 01/15/2014 | CN103505696A Traditional Chinese medicine combination for treating breast hyperplasia and preparation method thereof |
| 01/15/2014 | CN103505634A Traditional Chinese medicinal preparation for treating hemorrhoids |
| 01/15/2014 | CN103505613A Traditional Chinese medicine composition containing fatty acid and preparation method of composition |
| 01/15/2014 | CN103505610A Blood lipid reducing composition containing ginkgo leaves and fatty acid and preparation method of composition |
| 01/15/2014 | CN103505609A Blood lipid reducing composition containing sea buckthorn oil and preparation method of composition |
| 01/15/2014 | CN103505549A Medicine for treating alopecia seborrheica and preparation method thereof |
| 01/15/2014 | CN103505547A Traditional Chinese medicine composition for treating umbilical hernia |
| 01/15/2014 | CN103505527A Medicine for treating haemorrhoids |
| 01/15/2014 | CN103505525A Medicament for treating haemorrhoids and preparation method thereof |
| 01/15/2014 | CN103505510A Refreshing agent |
| 01/15/2014 | CN103505493A Blood lipid reducing composition containing eucommia seed oil and phytosterol and preparation method of composition |
| 01/15/2014 | CN103505489A Traditional Chinese medicine composition containing Sichuan lovage rhizome and preparation method of composition |
| 01/15/2014 | CN103505485A Pharmaceutical composition for preventing birth defects and improving memory |
| 01/15/2014 | CN103505484A Traditional Chinese medicine composition of total flavonoids of sea-buckthorn and linoleic acid and preparation method of composition |
| 01/15/2014 | CN103505482A Blood lipid reducing composition containing sea-buckthorn and glossy ganoderma and preparation method of composition |
| 01/15/2014 | CN103505478A Lucid ganoderma-Cordyceps sinensis granule and preparation method thereof |
| 01/15/2014 | CN103505476A Cell-free preparations of immunopotentiators, and preparation methods and uses thereof |